BioSpace News Archive

Cybin to Present at the Life Sciences Investor Forum on June 24th

Cybin Inc. today announced that Doug Drysdale, Chief Executive Officer, will be presenting at the Life Sciences Investor Forum on June 24, 2021.

June 23, 2021
·
3 min read
Drug Development

XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer

XBiotech Inc. has enrolled the first patient in its 1-BETTER study, a randomized, double-blind, placebo-controlled clinical study to evaluate XB2001 in combination chemotherapy for treatment of Pancreatic Cancer.

June 23, 2021
·
4 min read
Pharm Country

Janssen Submits New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients.

June 23, 2021
·
17 min read
Business

SpineCraft and Wishbone Medical Enter Distribution Agreement to Increase Access to Comprehensive Spine Deformity System for Pediatric Orthopedic Market

SpineCraft, LLC and WishBone Medical, Inc. announced a long-term distribution agreement pursuant to which WishBone will distribute SpineCraft’s ASTRA Spine Deformity System in several U.S. markets—with focus on the pediatric spine deformity segment.

June 23, 2021
·
3 min read
Drug Development

Children’s Cancer Research Fund Supports AOST-2121 PhIIb Clinical Trial in Recurred, Resected Osteosarcoma

Children’s Cancer Research Fund announced the support of OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma and other deadly cancers in kids and adults.

June 23, 2021
·
2 min read
Policy

Public Health Vaccines Awarded First Options Under Advanced Development Contract From BARDA to Continue Development of Vaccine Against Marburg Virus

Public Health Vaccines, LLC, a biotechnology company out of Cambridge, MA, has been awarded the first two options under its Biomedical Advanced Research and Development Authority contract for the advanced development of its vaccine candidate designed to prevent Marburg virus infections.

June 23, 2021
·
2 min read
German-Indian Biotech Company’s Nutraceutical Compound Shows Promising Use An Adjuvant To Treat COVID-19 In Randomized Clinical Trial

Vedicinals Pvt Ltd, a German-Indian biotech company based in Pune, India has recently announced the results of a WHO registered randomized clinical trial using its Indian regulatory authority approved nutraceutical compound called Vedicinals9.

June 23, 2021
·
6 min read
Business

Edesa Biotech Team Expands Leadership Team with Key Manufacturing Appointment

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced the appointment of a key member to its management team to support the company’s expanding manufacturing activities.

June 23, 2021
·
5 min read
Business

Veradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research Network

Veradigm®, and PRA Health Sciences, Inc. (NASDAQ: PRAH), announced today the creation of the industry’s leading electronic healthcare records-based clinical research network that reaches more than 25,000 physicians and 40 million patients across the United States.

June 23, 2021
·
5 min read
Genetown

Strand Therapeutics Raises $52M in Oversubscribed Series A Round

Strand Therapeutics today announced that the company raised $52 million in an oversubscribed Series A financing round.

June 23, 2021
·
4 min read